Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague
- PMID: 25605764
- PMCID: PMC4363438
- DOI: 10.1128/IAI.02778-14
Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague
Abstract
Previously, we showed that deletion of genes encoding Braun lipoprotein (Lpp) and MsbB attenuated Yersinia pestis CO92 in mouse and rat models of bubonic and pneumonic plague. While Lpp activates Toll-like receptor 2, the MsbB acyltransferase modifies lipopolysaccharide. Here, we deleted the ail gene (encoding the attachment-invasion locus) from wild-type (WT) strain CO92 or its lpp single and Δlpp ΔmsbB double mutants. While the Δail single mutant was minimally attenuated compared to the WT bacterium in a mouse model of pneumonic plague, the Δlpp Δail double mutant and the Δlpp ΔmsbB Δail triple mutant were increasingly attenuated, with the latter being unable to kill mice at a 50% lethal dose (LD50) equivalent to 6,800 LD50s of WT CO92. The mutant-infected animals developed balanced TH1- and TH2-based immune responses based on antibody isotyping. The triple mutant was cleared from mouse organs rapidly, with concurrent decreases in the production of various cytokines and histopathological lesions. When surviving animals infected with increasing doses of the triple mutant were subsequently challenged on day 24 with the bioluminescent WT CO92 strain (20 to 28 LD50s), 40 to 70% of the mice survived, with efficient clearing of the invading pathogen, as visualized in real time by in vivo imaging. The rapid clearance of the triple mutant, compared to that of WT CO92, from animals was related to the decreased adherence and invasion of human-derived HeLa and A549 alveolar epithelial cells and to its inability to survive intracellularly in these cells as well as in MH-S murine alveolar and primary human macrophages. An early burst of cytokine production in macrophages elicited by the triple mutant compared to WT CO92 and the mutant's sensitivity to the bactericidal effect of human serum would further augment bacterial clearance. Together, deletion of the ail gene from the Δlpp ΔmsbB double mutant severely attenuated Y. pestis CO92 to evoke pneumonic plague in a mouse model while retaining the required immunogenicity needed for subsequent protection against infection.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Figures













Similar articles
-
Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.Clin Vaccine Immunol. 2015 Dec;22(12):1255-68. doi: 10.1128/CVI.00499-15. Epub 2015 Oct 7. Clin Vaccine Immunol. 2015. PMID: 26446423 Free PMC article.
-
Deletion of the Braun lipoprotein-encoding gene and altering the function of lipopolysaccharide attenuate the plague bacterium.Infect Immun. 2013 Mar;81(3):815-28. doi: 10.1128/IAI.01067-12. Epub 2012 Dec 28. Infect Immun. 2013. PMID: 23275092 Free PMC article.
-
Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.Infect Immun. 2008 Apr;76(4):1390-409. doi: 10.1128/IAI.01529-07. Epub 2008 Jan 28. Infect Immun. 2008. PMID: 18227160 Free PMC article.
-
Yersinia pestis and pneumonic plague: Insight into how a lethal pathogen interfaces with innate immune populations in the lung to cause severe disease.Cell Immunol. 2024 Sep-Oct;403-404:104856. doi: 10.1016/j.cellimm.2024.104856. Epub 2024 Jul 10. Cell Immunol. 2024. PMID: 39002222 Review.
-
Immune defense against pneumonic plague.Immunol Rev. 2008 Oct;225:256-71. doi: 10.1111/j.1600-065X.2008.00674.x. Immunol Rev. 2008. PMID: 18837787 Free PMC article. Review.
Cited by
-
Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.mBio. 2021 Dec 21;12(6):e0322321. doi: 10.1128/mBio.03223-21. Epub 2021 Dec 7. mBio. 2021. PMID: 34872353 Free PMC article.
-
Contributions of Yersinia pestis outer membrane protein Ail to plague pathogenesis.Curr Opin Infect Dis. 2022 Jun 1;35(3):188-195. doi: 10.1097/QCO.0000000000000830. Curr Opin Infect Dis. 2022. PMID: 35665712 Free PMC article. Review.
-
Yersinia pestis and Plague: some knowns and unknowns.Zoonoses. 2023;3(1):5. doi: 10.15212/zoonoses-2022-0040. Epub 2023 Jan 19. Zoonoses. 2023. PMID: 37602146 Free PMC article.
-
Plague Vaccines: Status and Future.Adv Exp Med Biol. 2016;918:313-360. doi: 10.1007/978-94-024-0890-4_12. Adv Exp Med Biol. 2016. PMID: 27722869 Free PMC article. Review.
-
A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform.NPJ Vaccines. 2021 Jan 29;6(1):21. doi: 10.1038/s41541-020-00275-3. NPJ Vaccines. 2021. PMID: 33514747 Free PMC article.
References
-
- Achtman M, Morelli G, Zhu P, Wirth T, Diehl I, Kusecek B, Vogler AJ, Wagner DM, Allender CJ, Easterday WR, Chenal-Francisque V, Worsham P, Thomson NR, Parkhill J, Lindler LE, Carniel E, Keim P. 2004. Microevolution and history of the plague bacillus, Yersinia pestis. Proc Natl Acad Sci U S A 101:17837–17842. doi:10.1073/pnas.0408026101. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical